12-4. Delivery to cerebral infarction site│レナセラピューティクス株式会社

12-4. Delivery to cerebral infarction site

Identification of new ligands applicable to HDO

Company Name

Rena Therapeutics Inc.

Address

Global Business Hub Tokyo, Otemachi Finacial City Ground Cube 3F
9-2, Otemachi 1-chome, Chiyoda-ku, Tokyo 100-0004
＊Otemachi Station
C3 ext. 1 min.
＊Tokyo Station
Marsunouchi ext. 7 min.

Tel

+81 3-4243-6081